文献速递前列腺增生与排尿功能障碍

高危患者HoLEP术中脊髓麻醉与全身麻醉比较的倾向性评分匹配分析

Spinal Versus General Anesthesia for Holmium Laser Enucleation of the Prostate of High-risk Patients - A Propensity-score-matched-analysis.
PubMed 文献 · Urology · 2021-07-31

本回顾性倾向性评分匹配分析纳入300例行HoLEP的下尿路症状患者,比较高危(ASA>2)患者中脊髓麻醉(SpA)与全身麻醉(GA)的围手术期管理及功能结局。结果显示SpA组低血压事件更少、PACU停留更短、术后镇痛需求更低,且早期功能结局与治疗相关不良事件无显著差异。提示SpA是高危患者HoLEP安全有效的麻醉替代方案。

要点

  • 高危患者HoLEP中SpA组低血压发生率9%,显著低于GA高危组32%和GA低危组22%。
  • SpA组PACU中位时间135分钟,短于GA高危组186分钟,且中转ICU率更低(1% vs 9%)。
  • SpA组术后镇痛需求2%,显著低于GA两组的74%和61%,功能结局与不良事件无差异。

核心结论

  • 高危患者行HoLEP时,SpA提供更佳血流动力学稳定性和更快术后恢复,且镇痛管理更优,可作为GA的安全有效替代。

研究设计与样本

  • 回顾性倾向性评分匹配分析,纳入300例行HoLEP的下尿路症状患者,分为SpA且ASA>2组(n=100)、GA且ASA>2组(n=100)和GA且ASA≤2组(n=100)。

主要发现

  • SpA组低血压发生率9%,显著低于GA高危组32%和GA低危组22%(各P<.05)。
  • SpA组PACU中位时间135分钟(120-166.5),显著短于GA高危组186分钟(154-189.5)(P<.05)。
  • SpA组中转ICU率1%,显著低于GA高危组9%(P<.05)。
  • SpA组术后镇痛需求2%,显著低于GA高危组74%和GA低危组61%(P<.05)。
  • 早期功能结局和治疗相关不良事件(Clavien-Dindo分级)在各组间无显著差异(P范围0.201-1.000)。

关键数值与推荐

  • SpA组低血压9% vs GA高危组32% vs GA低危组22%(各P<.05)。
  • SpA组PACU中位时间135分钟(120-166.5) vs GA高危组186分钟(154-189.5)(P<.05)。
  • SpA组中转ICU率1% vs GA高危组9%(P<.05);GA低危组PACU时间99分钟、中转ICU率0%。
  • SpA组术后镇痛需求2% vs GA高危组74% vs GA低危组61%(P<.05)。
  • 功能结局与不良事件组间无显著差异(P范围0.201-1.000)。

临床怎么用

  • 对高危(ASA>2)拟行HoLEP的患者,可优先考虑脊髓麻醉以降低低血压风险、缩短PACU停留并减少术后镇痛需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare perioperative management and functional outcome of spinal anesthesia (SpA) to general anesthesia (GA) in high-risk patients treated for lower urinary tract symptoms with Holmium laser enucleation of the prostate (HoLEP). METHODS: In the current retrospective analysis, a propensity-score-matching of patients treated for lower urinary tract symptom with HoLEP (n = 300) in SpA with ASA>2 (n = 100), GA with ASA>2 (GA-high-risk) (n = 100) or GA with ASA≤2 (GA-low-risk) (n = 100) was performed. The impact of anesthesiologic mode on perioperative anesthesiologic outcome, early functional outcome and treatment related adverse events (according to Clavien Dindo), was evaluated. RESULTS: Hypotensive episodes were significantly less frequent in the SpA-cohort (9%) compared to the GA-high-risk cohort (32%) and the GA low-risk cohort (22%) (each P <.05 respectively). SpA-patients showed a significantly shorter median time in post anesthesia care unit (PACU-time: 135 minutes; 120-166.5) compared to GA-high-risk patients (186 minutes; 154-189.5), with significant less referrals to Intermediate care unit (1% vs 9 %); (each P <.05). PACU-time (99 minutes) and Intermediate care unit referrals (0%) for GA-low-risk were lower than for both other cohorts. Postoperative requirement for analgesics was significantly lower in the SpA-cohort (2%), compared to both GA-cohorts (74% and 61% respectively; P <.05). No significant difference was found regarding early functional outcome or treatment related adverse events (p-range: 0.201-1.000). CONCLUSION: For patients undergoing HoLEP, SpA provides greater hemodynamic stability and allows faster overall postoperative recovery with preferable pain management. Yielding a comparable functional outcome, it is a safe and efficient alternative to GA in high-risk patients.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Westhofen T, Schott M, Keller P, et al. Spinal Versus General Anesthesia for Holmium Laser Enucleation of the Prostate of High-risk Patients - A Propensity-score-matched-analysis. Urology. 2021. PMID: 34339752. doi:10.1016/j.urology.2021.04.078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。